AzTrials
AzTrials

GingivaNCT06981871

Prevalence of Lower and Upper Incisor Periodontal Phenotypes and Risk Indicators.

An observational study of Gingiva and Phenotype, run by Centre Hospitalier Universitaire de Nice at 1 site in France.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The determination of the periodontal phenotype is an essential part of the periodontal diagnostic process, which must guide not only treatment but also prognosis (Kim et al. 2020). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Gingiva, Phenotype
What is being tested?
Evaluation of the gingival phenotype of the incisors in the upper and lower jaws
How many people
245 participants
Where
1 siteFrance
Study dates
1 Jun 2025to 1 Nov 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Study population: Dental students at the university hospitals of Nice and Nancy (France)

Who may be able to join

  • Age (18 years old or older),
  • Dental student on the university hospitals of Nice and Nancy.
  • Social security affiliate.
  • Systemically healthy.
  • Healthy and intact periodontium.
  • Informed consent.

Who cannot join

  • Pregnancy.
  • Under any regular medical treatment.
  • Active periodontal disease.
  • Enduring orthodontic treatment.
  • Periodontal surgery in the mandibulary anterior region.
  • Non consent patient.
  • Patient under judgment trials.

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU NICE

    Nice, Alpes Maritimes, 06000

Other trials in France

About this study

Official title: Prevalence of Lower and Upper Incisor Periodontal Phenotypes and Risk Indicators in French Dental Students: a Bicentric Cross-sectional Study

The determination of the periodontal phenotype is an essential part of the periodontal diagnostic process, which must guide not only treatment but also prognosis (Kim et al. 2020).

This determination is based on the clinical assessment of 3 individual variables: gingival height/thickness and alveolar bone cortical thickness. Although these anatomical characteristics are genetically determined, they are also influenced by numerous acquired, endogenous or exogenous factors that can act at a general and/or local level. The periodontal phenotype is therefore specific to an individual and its 3 components vary over time according to the dental sectors and sites of each individual. For example, the morphology of this phenotype varies according to whether the gingiva is thick or thin, high or reduced, and the bone cortex is thick or thin, with all possible combinations. Clinicians need to know the distribution of these different types of phenotypes, particularly in the aesthetic areas they are concerned with, in order to better identify the most fragile ones in the face of the multiple daily stresses to which the periodontium may be subjected: muscular force, dental plaque, oral hygiene manoeuvres, parafunctionality, dental procedures....

However, studies on the prevalence of the periodontal phenotype are limited and mainly concern Asian, Indian and American populations, with very few studies on European populations. Main objective: To assess the prevalence of periodontal phenotypes in the upper and lower incisors of French subjects, according to tooth type and at the individual level. Secondary objective: Identification of potential risk indicators in relation to the type of periodontal phenotype."

Conditions
Gingiva, Phenotype
Being tested
Evaluation of the gingival phenotype of the incisors in the upper and lower jaws

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Evaluation of the gingival phenotype of the incisors in the upper and lower jawsOther

    Assessment of gingival thickness (Kan et al 2015) and keratinised tissue height of the incisors with UNC-15 peridontal probe (Hu-Freidy, USA) and clinical photography.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Prevalence of gingival phenotypes (gingival thickness )

    Assessment of gingival thickness

    Measured: At the inclusion

  2. Prevalence of gingival phenotypes (keratinised tissue height)

    Evaluation of keratinised tissue height of the lower and upper incisors with UNC-15 peridontal probe (mm) and clinical photography.

    Measured: At the inclusion

  3. Prevalence of gingival phenotypes (Photography)

    Description of the gingiva

    Measured: At the inclusion

Secondary outcomes (2)
  1. Associated risk indicators for thin gingival phenotype ( Clinical description)

    Global description clinical multiples evaluations ( Age, gender, smoking habit, orthodontic background, oral hygiene habit, oral ventilation, dysfunction, facial typology, chin shape, visibility of vascularisation and root convexity through the gum, gingival récession (Cairo), freinal insertion and skin type).

    Measured: At the inclusion

  2. Associated risk indicators for thin gingival phenotype ( orthodontic and facial characteristics )

    Global description clinical evaluation based on photographs.

    Measured: At the inclusion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 May 2025
  2. Study start1 Jun 2025
  3. Primary completion1 Nov 2026 (estimated)
  4. Study completion1 Nov 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
245 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06981871
Sponsor's protocol ID
25Odonto02
Status last verified
Sep 2026
First submitted
13 May 2025
Last updated
18 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Gingiva and Phenotype, run by Centre Hospitalier Universitaire de Nice at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 18 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Prevalence of gingival phenotypes (gingival thickness ) (time frame: At the inclusion). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in